Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Beyond Meat, Nikola, Newlox: meat replacement, hydrogen, and green gold

The quest for a better world coupled with economic success motivates investors around the globe to participate in innovation and business ideas. These are often subjects that promote health and protect the environment. Those who think big and plan ahead receive the relevant at...
Mario Hose | September 30, 2020 |

The Company that’s taking Psychedelics from ‘Underground to Mainstream’

(Click image to play video) On a trip to Amsterdam, an item on many traveler’s agendas would be to indulge in some famed Dutch truffles. It is an experience to heighten the mind that Canadian public Company Red Light Holland Corp. (TRIP) ( CSE: T...
Dave Jackson | February 2, 2021 |

Coverage Initiated on Maker of Antibiotic-Free Supplement for Livestock Feed

The highlights of this investment story are outlined in a Zacks Small-Cap Research report. In a Nov. 19 research note, analyst David Bautz reported that Zacks Small-Cap Research initiated coverage on Avivagen Inc. (VIV:TSX.V; CHEXF:OTCMKTS) with a US$2.50 valuation....
Streetwise Reports | November 27, 2019 |

Axsome Therapeutics Investors Awaken to Positive Outcome in Phase 2 Narcolepsy Trial

Axsome Therapeutics shares traded 14% higher today after the company reported that its narcolepsy drug candidate AXS-12 achieved its primary endpoint in the Phase 2 CONCERT Study. This morning before U.S. markets opened, clinical-stage biopharmaceutical company Axsom...
Streetwise Reports | December 4, 2019 |

Industry expert details how to invest in copper

With more than 22 billion pounds of additional copper supply required in 2035 just to meet the copper demand for electric vehicles, you might be wondering if now is a good time to add copper to your portfolio. Joining The Market Herald Canada to talk about the dem...
Coreena Robertson | August 17, 2023 |

Saturn Oil & Gas, TORC Oil & Gas, Whitecap Resources - it's time for harmless oil!

In recent years, there has been a growing trend in modern society that food must originate from the region and a declaration as 'organic' is now considered mandatory. Coffee beans from distant countries should definitely carry the label 'Fairtrade' and blood diamonds are right...
Mario Hose | January 20, 2020 |

Burcon, Canopy, dynaCERT - how cannabis, proteins and hydrogen improve the world

Innovations continuously change our lives. Entrepreneurs around the globe are trying to make things happen, developing products and technologies that are designed to improve everyday life. Business areas that are scalable are particularly successful. Once a product is ready to...
Mario Hose | January 27, 2020 |

Bond sell-off is due to become more serious

With my indicators on a sell signal for bonds since August 16, I have been warning about bonds being overbought and in danger of rolling over into a serious correction for several months. And indeed, the 20-year U.S. Treasury bond has already lost 11% of its value just since...
Sy Harding | January 7, 2013 |

PDS Biotech Collaborating with Merck in Phase 2 Cancer Trial

This morning PDS Biotechnology Corp. shares are trading 38% higher after reporting that it will enter into a clinical collaboration with Merck pairing the firm's PDS0101 with KEYTRUDA for patients with recurrent or metastatic head and neck cancer and high-risk HPV16 infection....
Streetwise Reports | October 4, 2019 |

China Social Media Firm Gains 55 Million Monthly Active Users

Weibo Corp. (WB:NASDAQ) , a leading Chinese social media platform company with nearly 500 million monthly active users, today announced its unaudited financial results for the second quarter ended June 30, 2019. In the report, the firm reported total n...
Streetwise Reports | August 20, 2019 |
1 2 3 4 5 6